Melatonin Use in Autism Spectrum Disorders

Reference work entry

Abstract

Melatonin is a neurohormone secreted by the pineal gland. It is synthesized from the amino acid tryptophan and undergoes catabolism in the body. These children commonly have disturbances with their sleep, with the most common being insomnia. Melatonin has been used quite effectively in this subgroup of children; however, optimal dosing is still not clear.

Keywords

Fatigue Depression Adenosine Serotonin Retina 

References

  1. Andersen IM, Kaczmarska J, McGrew SG, et al. Melatonin for insomnia in children with autism spectrum disorders. J Child Neurol. 2008;23:482–5.PubMedCrossRefGoogle Scholar
  2. Arendt J. Aaron Lerner, who discovered melatonin. J Pineal Res. 2007;43:106–7.PubMedCrossRefGoogle Scholar
  3. Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Med Rev. 2005;9:25–39.PubMedCrossRefGoogle Scholar
  4. Attenburrow ME, Cowen PJ, Sharpley AL. Low dose melatonin improves sleep in healthy middle-aged subjects. Psychopharmacology (Berl). 1996;126:179–81.CrossRefGoogle Scholar
  5. Birkeland AJ. Plasma melatonin levels and nocturnal transitions between sleep and wakefulness. Neuroendocrinology. 1982;34:126–31.PubMedCrossRefGoogle Scholar
  6. Bourgeron T. The possible interplay of synaptic and clock genes in autism spectrum disorders. Cold Spring Harb Symp Quant Biol. 2007;72:645–54.PubMedCrossRefGoogle Scholar
  7. Braam W, Didden R, Maas AP, Korzilius H, et al. Melatonin decreases daytime challenging behaviour in persons with intellectual disability and chronic insomnia. J Intellect Disabil Res. 2010;54:52–9.PubMedCrossRefGoogle Scholar
  8. Carter M, Calcutt M, Malow B, et al. Quantitation of melatonin and n-acetylserotonin in human plasma by nanoflow LC-MS/MS and electrospray LC-MS/MS. J Mass Spectrom. 2012;47:277–85.PubMedCrossRefGoogle Scholar
  9. Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev. 2005;9:11–24.PubMedCrossRefGoogle Scholar
  10. Cotton S, Richdale A. Brief report: parental descriptions of sleep problems in children with autism, down syndrome, and prader-willi syndrome. Res Dev Disabil. 2006;27:151–61.PubMedCrossRefGoogle Scholar
  11. Cricco M, Simonsick EM, Foley DJ. The impact of insomnia on cognitive functioning in older adults. J Am Geriatr Soc. 2001;49:1185–9.PubMedCrossRefGoogle Scholar
  12. De Leersnyder H, De Blois MC, Claustrat B, et al. Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. J Pediatr. 2001;139:111–6.PubMedCrossRefGoogle Scholar
  13. Dijk DJ, von Schantz M. Timing and consolidation of human sleep, wakefulness, and performance by a symphony of oscillators. J Biol Rhythms. 2005;20:279–90.PubMedCrossRefGoogle Scholar
  14. Doo S, Wing YK. Sleep problems of children with pervasive developmental disorders: correlation with parental stress. Dev Med Child Neurol. 2006;48:650–5.PubMedCrossRefGoogle Scholar
  15. Dollins AB, Zhdanova IV, Wurtman RJ, et al. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci USA. 1994;91:1824–8.PubMedCrossRefGoogle Scholar
  16. Doyen C, Mighiu D, Kaye K, et al. Melatonin in children with autistic spectrum disorders: recent and practical data. Eur Child Adolesc Psychiatry. 2011;20:231–9.PubMedCrossRefGoogle Scholar
  17. Galli-Carminati G, Deriaz N, Bertschy G. Melatonin in treatment of chronic sleep disorders in adults with autism: a retrospective study. Swiss Med Wkly. 2009;139:293–6.PubMedGoogle Scholar
  18. Garstang J, Wallis M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev. 2006;32:585–9.PubMedCrossRefGoogle Scholar
  19. Giannotti F, Cortesi F, Cerquiglini A, et al. An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. J Autism Dev Disord. 2006;36:741–52.PubMedCrossRefGoogle Scholar
  20. Giannotti F, Cortesi F, Cerquig, et al. An investigation of sleep characteristics, EEG abnormalities and epilepsy in developmentally regressed and non-regressed children with autism. J Autism Dev Disord. 2008;38:1888–97.PubMedCrossRefGoogle Scholar
  21. Glickman G. Circadian rhythms and sleep in children with autism. Neurosci Biobehav Rev. 2010;34:755–68.PubMedCrossRefGoogle Scholar
  22. Gupta R, Hutchins J. Melatonin: a panacea for desperate parents? (Hype or truth). Arch Dis Child. 2005;90:986–7.PubMedCrossRefGoogle Scholar
  23. Hayashi E. Effect of melatonin on sleep-wake rhythm: the sleep diary of an autistic male. Psychiatry Clin Neurosci. 2000;54:383–4.PubMedCrossRefGoogle Scholar
  24. Hirata F, Hayaishi O, Tokuyama T, et al. In vitro and in vivo formation of two new metabolites of melatonin. J Biol Chem. 1974;249:1311–3.PubMedGoogle Scholar
  25. Horrigan JP, Barnhill LJ. More on melatonin. J Am Acad Child Adolesc Psychiatry. 1997;36:1014.PubMedCrossRefGoogle Scholar
  26. Jan JE, Espezel H, Appleton RE. The treatment of sleep disorders with melatonin. Dev Med Child Neurol. 1994;36:97–107.PubMedCrossRefGoogle Scholar
  27. Jan JE, Freeman RD, Wasdell MB, et al. A child with severe night terrors and sleep-walking responds to melatonin therapy. Dev Med Child Neurol. 2004;46:789.PubMedCrossRefGoogle Scholar
  28. Jang SW, Liu X, Pradoldej S, et al. N-acetylserotonin activates TrkB receptor in a circadian rhythm. Proc Natl Acad Sci USA. 2010;107:3876–81.PubMedCrossRefGoogle Scholar
  29. Jin X, von Gall C, Pieschl RL, et al. Targeted disruption of the mouse mel (1b) melatonin receptor. Mol Cell Biol. 2003;23:1054–60.PubMedCrossRefGoogle Scholar
  30. Kato K, Hirai K, Nishiyama K, et al. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology. 2005;48:301–10.PubMedCrossRefGoogle Scholar
  31. Klein DC, Weller JL, Moore RY. Melatonin metabolism: neural regulation of pineal serotonin: acetyl coenzyme A N-acetyltransferase activity. Proc Natl Acad Sci USA. 1971;68:3107–10.PubMedCrossRefGoogle Scholar
  32. Klein DC, Schaad NL, Namboordiri MA, et al. Regulation of pineal serotonin N-acetyltransferase activity. Biochem Soc Trans. 1992;20:299–304.PubMedGoogle Scholar
  33. Konturek PC, Brzozowski T, Konturek SJ. Gut clock: implication of circadian rhythms in the gastrointestinal tract. J Physiol Pharmacol. 2011;62:139–50.PubMedGoogle Scholar
  34. Konstantareas MM, Homatidis S. Assessing child symptom severity and stress in parents of autistic children. J Child Psychol Psychiatry. 1989:30;459–70.PubMedCrossRefGoogle Scholar
  35. Krakowiak P, Goodlin-Jones B, Hertz-Picciotto I, et al. Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study. J Sleep Res. 2008;17;197–206.PubMedCrossRefGoogle Scholar
  36. Kripke DF, Nievergelt CM, Tranah GJ, et al. Polymorphisms in melatonin synthesis pathways: possible influences on depression. J Circadian Rhythms. 2011;9:8.PubMedCrossRefGoogle Scholar
  37. Kulman G, Lissoni P, Rovelli F, et al. Evidence of pineal endocrine hypofunction in autistic children. Neuro Endocrinol Lett. 2000;21:31–4.PubMedGoogle Scholar
  38. Leu RM, Beyderman L, Botzolakis EJ, et al. Relation of melatonin to sleep architecture in children with autism. J Autism Dev Disord. 2011;41:427–33.PubMedCrossRefGoogle Scholar
  39. Leyfer OT, Folstein SE, Bacalman S, et al. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord. 2006;36:849–61.PubMedCrossRefGoogle Scholar
  40. Liu X, Hubbard JA, Fabes RA, et al. Sleep disturbances and correlates of children with autism spectrum disorders. Child Psychiatry Hum Dev. 2006;37:179–91.PubMedCrossRefGoogle Scholar
  41. Ma X, Idle JR, Krausz KW, et al. Metabolism of melatonin by human cytochromes p450. Drug Metab Dispos. 2005;33:489–94.PubMedCrossRefGoogle Scholar
  42. Malow BA, McGrew SG, Harvey M, et al. Impact of treating sleep apnea in a child with autism spectrum disorder. Pediatr Neurol. 2006a;34:325–8.PubMedCrossRefGoogle Scholar
  43. Malow BA, Marzec ML, McGrew SG, et al. Characterizing sleep in children with autism spectrum disorders: a multidimensional approach. Sleep. 2006b;29:1563–71.PubMedGoogle Scholar
  44. Malow B, Adkins KW, McGrew SG, et al. Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes. J Autism Dev Disord. 2012;42:1729–37.Google Scholar
  45. Meltzer LJ. Brief report: sleep in parents of children with autism spectrum disorders. J Pediatr Psychol. 2008;33:380–6.PubMedCrossRefGoogle Scholar
  46. Melke J, Goubran Botros H, Chaste P, et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry. 2008;13:90–8.PubMedCrossRefGoogle Scholar
  47. Morin LP, Allen CN. The circadian visual system, 2005. Brain Res Rev. 2006;51:1–60.PubMedCrossRefGoogle Scholar
  48. Nir I, Meir D, Zilber N, et al. Brief report: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J Autism Dev Disord. 1995;25:641–54.PubMedCrossRefGoogle Scholar
  49. Owens JA. The ADHD and sleep conundrum: a review. J Dev Behav Pediatr. 2005;26:312–22.PubMedCrossRefGoogle Scholar
  50. Paavonen EJ, Nieminen-von Wendt T, Vanhala R, et al. Effectiveness of melatonin in the treatment of sleep disturbances in children with asperger disorder. J Child Adolesc Psychopharmacol. 2003;13:83–95.PubMedCrossRefGoogle Scholar
  51. Pandi-Perumal SR, Srinivasan V, Maestroni GJ, et al. Melatonin: nature’s most versatile biological signal? FEBS J. 2006;273:2813–38.PubMedCrossRefGoogle Scholar
  52. Patzold LM, Richdale AL, Tonge BJ. An investigation into sleep characteristics of children with autism and Asperger's Disorder. J Paediatr Child Health. 1998;34:528–33.PubMedCrossRefGoogle Scholar
  53. Phillips L, Appleton RE. Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment. Dev Med Child Neurol. 2004;46:771–5.PubMedCrossRefGoogle Scholar
  54. Reiter RJ. Melatonin: clinical relevance. Best Pract Res Clin Endocrinol Metab. 2003;17:273–85.PubMedCrossRefGoogle Scholar
  55. Reppert SM, Godson C, Mahle CD, et al. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA. 1995;92:8734–8.PubMedCrossRefGoogle Scholar
  56. Richdale AL. Sleep problems in autism: prevalence, cause, and intervention. Dev Med Child Neurol. 1999;41:60–6.PubMedCrossRefGoogle Scholar
  57. Richdale AL, Schreck KA. Sleep problems in autism spectrum disorders: prevalence, nature, & possible biopsychosocial aetiologies. Sleep Med Rev. 2009;13:403–11.PubMedCrossRefGoogle Scholar
  58. Richdale AL, Prior MR. The sleep/wake rhythm in children with autism. Eur Child Adolesc Psychiatry. 1995;4:175–86.PubMedCrossRefGoogle Scholar
  59. Robinson AM, Richdale AL. Sleep problems in children with an intellectual disability: parental perceptions of sleep problems, and views of treatment effectiveness. Child Care Health Dev. 2004;30:139–50.PubMedCrossRefGoogle Scholar
  60. Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol. 2011;53:783–92.PubMedCrossRefGoogle Scholar
  61. Sack RL, Hughes RJ, Edgar DM, et al. Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms? Sleep. 1997;20:908–15.PubMedGoogle Scholar
  62. Schreck KA, Mulick JA, Smith AF. Sleep problems as possible predictors of intensified symptoms of autism. Res Dev Disabil. 2004;25:57–66.PubMedCrossRefGoogle Scholar
  63. Sheldon SH. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet. 1998;351:1254.PubMedCrossRefGoogle Scholar
  64. Smith AC, Dykens E, Greenberg F. Behavioral phenotype of smith-magenis syndrome (del 17p11.2). Am J Med Genet. 1998;81:179–85.PubMedCrossRefGoogle Scholar
  65. Souders MC, Mason TB, Valladares O, et al. Sleep behaviors and sleep quality in children with autism spectrum disorders. Sleep. 2009;32:1566–78.PubMedGoogle Scholar
  66. Tordjman S, Anderson GM, Pichard N, et al. Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biol Psychiatry. 2005;57:134–8.PubMedCrossRefGoogle Scholar
  67. Tricoire H, Moller M, Chemineau P, et al. Origin of cerebrospinal fluid melatonin and possible function in the integration of photoperiod. Reprod Suppl. 2003;61:311–21.PubMedGoogle Scholar
  68. Waldhauser F, Steger H. Changes in melatonin secretion with age and pubescence. J Neural Transm Suppl. 1986;21:183–97.PubMedGoogle Scholar
  69. Weaver DR. Reproductive safety of melatonin: a “wonder drug” to wonder about. J Biol Rhythms. 1997;12:682–9.PubMedCrossRefGoogle Scholar
  70. Wiggs L, Stores G. Sleep patterns and sleep disorders in children with autistic spectrum disorders: insights using parent report and actigraphy. Dev Med Child Neurol. 2004;46:372–80.PubMedCrossRefGoogle Scholar
  71. Wirojanan J, Jacquemont S, Diaz R, et al. The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. J Clin Sleep Med. 2009;5:145–50.PubMedGoogle Scholar
  72. Wright B, Sims D, Smart S, et al. Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial. J Autism Dev Disord. 2011;41:175–84.PubMedCrossRefGoogle Scholar
  73. Zhdanova IV. Melatonin as a hypnotic: pro. Sleep Med Rev. 2005;9:51–65.PubMedCrossRefGoogle Scholar
  74. Zhdanova IV, Wurtman RJ, Lynch HJ, et al. Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther. 1995;57:552–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Pediatrics, College of MedicineUniversity of Arkansas for Medical SciencesLittle RockUSA
  2. 2.Vanderbilt Kennedy CenterVanderbilt UniversityNashvilleUSA

Personalised recommendations